Literature DB >> 28210005

MLL is essential for NUP98-HOXA9-induced leukemia.

Y Shima1, M Yumoto1, T Katsumoto1, I Kitabayashi1.   

Abstract

Rearrangements involving the NUP98 gene resulting in fusions to several partner genes occur in acute myeloid leukemia and myelodysplastic syndromes. This study demonstrates that the second FG repeat domain of the NUP98 moiety of the NUP98-HOXA9 fusion protein is important for its cell immortalization and leukemogenesis activities. We demonstrate that NUP98-HOXA9 interacts with mixed lineage leukemia (MLL) via this FG repeat domain and that, in the absence of MLL, NUP98-HOXA9-induced cell immortalization and leukemogenesis are severely inhibited. Molecular analyses indicate that MLL is important for the recruitment of NUP98-HOXA9 to the HOXA locus and for NUP98-HOXA9-induced HOXA gene expression. Our data indicate that MLL is crucial for NUP98-HOXA9 leukemia initiation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28210005     DOI: 10.1038/leu.2017.62

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  36 in total

1.  Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression.

Authors:  James J-D Hsieh; Emily H-Y Cheng; Stanley J Korsmeyer
Journal:  Cell       Date:  2003-10-31       Impact factor: 41.582

2.  Structure of HoxA9 and Pbx1 bound to DNA: Hox hexapeptide and DNA recognition anterior to posterior.

Authors:  Nicole A LaRonde-LeBlanc; Cynthia Wolberger
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

3.  Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.

Authors:  Akiko Takeda; Nayan J Sarma; Anmaar M Abdul-Nabi; Nabeel R Yaseen
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

4.  NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.

Authors:  Akiko Takeda; Charles Goolsby; Nabeel R Yaseen
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

5.  MLL targets SET domain methyltransferase activity to Hox gene promoters.

Authors:  Thomas A Milne; Scott D Briggs; Hugh W Brock; Mary Ellen Martin; Denise Gibbs; C David Allis; Jay L Hess
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

6.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

7.  The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia.

Authors:  Lars Palmqvist; Bob Argiropoulos; Nicolas Pineault; Carolina Abramovich; Laura M Sly; Gerald Krystal; Adrian Wan; R Keith Humphries
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

8.  Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation.

Authors:  Stephanie Y Jo; Eric M Granowicz; Ivan Maillard; Dafydd Thomas; Jay L Hess
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

9.  NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.

Authors:  Gang G Wang; Ling Cai; Martina P Pasillas; Mark P Kamps
Journal:  Nat Cell Biol       Date:  2007-06-24       Impact factor: 28.824

10.  Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties.

Authors:  Akihiko Yokoyama; Issay Kitabayashi; Paul M Ayton; Michael L Cleary; Misao Ohki
Journal:  Blood       Date:  2002-06-28       Impact factor: 22.113

View more
  17 in total

1.  CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.

Authors:  Johannes Schmoellerl; Inês Amorim Monteiro Barbosa; Thomas Eder; Tania Brandstoetter; Luisa Schmidt; Barbara Maurer; Selina Troester; Ha Thi Thanh Pham; Mohanty Sagarajit; Jessica Ebner; Gabriele Manhart; Ezgi Aslan; Stefan Terlecki-Zaniewicz; Christa Van der Veen; Gregor Hoermann; Nicolas Duployez; Arnaud Petit; Helene Lapillonne; Alexandre Puissant; Raphael Itzykson; Richard Moriggl; Michael Heuser; Roland Meisel; Peter Valent; Veronika Sexl; Johannes Zuber; Florian Grebien
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

2.  HOXA9 has the hallmarks of a biological switch with implications in blood cancers.

Authors:  Laure Talarmain; Matthew A Clarke; David Shorthouse; Lilia Cabrera-Cosme; David G Kent; Jasmin Fisher; Benjamin A Hall
Journal:  Nat Commun       Date:  2022-10-03       Impact factor: 17.694

3.  Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation.

Authors:  Bappaditya Chandra; Nicole L Michmerhuizen; Hazheen K Shirnekhi; Swarnendu Tripathi; Brittany J Pioso; David W Baggett; Diana M Mitrea; Ilaria Iacobucci; Michael R White; Jingjing Chen; Cheon-Gil Park; Huiyun Wu; Stanley Pounds; Anna Medyukhina; Khaled Khairy; Qingsong Gao; Chunxu Qu; Sherif Abdelhamed; Scott D Gorman; Simranjot Bawa; Carolyn Maslanka; Swati Kinger; Priyanka Dogra; Mylene C Ferrolino; Danika Di Giacomo; Cristina Mecucci; Jeffery M Klco; Charles G Mullighan; Richard W Kriwacki
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

Review 4.  Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.

Authors:  Nicole L Michmerhuizen; Jeffery M Klco; Charles G Mullighan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

Review 5.  Nuclear Periphery Takes Center Stage: The Role of Nuclear Pore Complexes in Cell Identity and Aging.

Authors:  Ukrae H Cho; Martin W Hetzer
Journal:  Neuron       Date:  2020-06-17       Impact factor: 18.688

Review 6.  Role of HOX Genes in Stem Cell Differentiation and Cancer.

Authors:  Seema Bhatlekar; Jeremy Z Fields; Bruce M Boman
Journal:  Stem Cells Int       Date:  2018-07-22       Impact factor: 5.443

7.  Transforming activities of the NUP98-KMT2A fusion gene associated with myelodysplasia and acute myeloid leukemia.

Authors:  James N Fisher; Angeliki Thanasopoulou; Sabine Juge; Alexandar Tzankov; Frederik O Bagger; Max A Mendez; Antoine H F M Peters; Juerg Schwaller
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

8.  Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.

Authors:  Adélia Mendes; Ramona Jühlen; Sabrina Bousbata; Birthe Fahrenkrog
Journal:  Cells       Date:  2020-07-10       Impact factor: 6.600

9.  The Role of the HOXA Gene Family in Acute Myeloid Leukemia.

Authors:  Si-Liang Chen; Zhe-Yuan Qin; Fang Hu; Yun Wang; Yu-Jun Dai; Yang Liang
Journal:  Genes (Basel)       Date:  2019-08-16       Impact factor: 4.096

Review 10.  NUP214 in Leukemia: It's More than Transport.

Authors:  Adélia Mendes; Birthe Fahrenkrog
Journal:  Cells       Date:  2019-01-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.